NCT01766713View on ClinicalTrials.gov

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Non Alcoholic Steatohepatitis
Interventions
DRUG

Ezetimibe

10mg daily oral dose of ezetimibe

Trial Locations (1)

92103

University of California, San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT01766713 - Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter